Viewing Study NCT07001618


Ignite Creation Date: 2025-12-25 @ 5:05 AM
Ignite Modification Date: 2025-12-26 @ 4:08 AM
Study NCT ID: NCT07001618
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-07-23
First Post: 2025-05-23
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Oral Pooled Fecal Microbiotherapy (MaaT033) Concomitant to Cemiplimab Versus Best Investigator's Choice in Patients With Resistance to Treatment Due to Antibiotics Uptake With Advanced Non-small Cell Lung Cancer
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module